Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03316794
Title A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie

triple-receptor negative breast cancer



Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago /ID# 169231 Chicago Illinois 60637-1443 United States Details
Washington University School /ID# 169177 Saint Louis Missouri 63108 United States Details
Memorial Sloan Kettering /ID# 201016 New York New York 10065 United States Details
Gabrail Cancer Center Research /ID# 168756 Canton Ohio 44718 United States Details
Oklahoma University /ID# 200937 Oklahoma City Oklahoma 73104 United States Details
Tennessee Oncology-Sarah Cannon Research Institute /ID# 169233 Nashville Tennessee 37203 United States Details
Baylor University /ID# 169860 Houston Texas 77030 United States Details
MD Anderson Cancer Center /ID# 169232 Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field